Clinical Trials for Lymphoma, Large B-Cell, Diffuse

Find clinical trials for lymphoma, large b-cell, diffuse. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

NCT ID: NCT06890884

This clinical trial is studying two different treatments for a type of fast-growing blood cancer called diffuse large B-cell lymphoma (DLBCL), specifically the germinal center B-cell-like subtype. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ramat Gan, , Israel, Jerusalem, , Israel +9 more

A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers

NCT ID: NCT06254495

This clinical trial is investigating a new drug called SGN-35C to see if it is safe for adults with advanced types of lymphoma, which is a cancer that affects the blood cells responsible for fighti...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States, Duarte, California, United States +54 more

A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers

NCT ID: NCT06120504

This clinical trial is investigating a new drug called SGN-35T for adults with advanced forms of lymphoma, a type of cancer that affects the blood cells responsible for fighting infections. The tri...

Recruiting

Phase: PHASE1 Type: interventional Locations: Buffalo, New York, United States, Iowa City, Iowa, United States +42 more

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

NCT ID: NCT06045910

This clinical trial is studying a new treatment called ALETA-001 for patients with certain types of B-cell cancers, including different forms of lymphoma. Specifically, it is looking at how safe an...

Recruiting

Phase: PHASE1 Type: interventional Locations: London, , United Kingdom, Manchester, , United Kingdom +7 more

CD70-targeted immunoPET Imaging of Malignant Cancers

NCT ID: NCT06852638

This clinical trial is looking at a new imaging method called CD70-targeted immunoPET/CT, which aims to help doctors spot certain types of cancers, including renal cancer (specifically clear cell r...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, , China

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

NCT ID: NCT06573645

This clinical trial is studying a new treatment approach for male patients with advanced diffuse large B-cell lymphoma (DLBCL), a type of blood cancer. Researchers want to find out if using a highe...

Not yet recruiting

Phase: PHASE3 Type: interventional

Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL

NCT ID: NCT06289959

This clinical trial is studying a new way to guide treatment decisions for patients with diffuse large B-cell lymphoma (DLBCL), a type of cancer that affects the lymphatic system. Researchers want ...

Not yet recruiting

Phase: NA Type: interventional Locations: Suzhou, Jiangsu, China

Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma

NCT ID: NCT05923879

This clinical trial is looking at how a combination of three medications—Selinexor, lenalidomide, and rituximab—can help treat patients with diffuse large B-cell lymphoma, a type of cancer affectin...

Not yet recruiting

Type: observational Locations: Shanghai, Shanghai, China, Shanghai, , China

ChiCGB vs BEAM in High-risk or R/R Lymphomas

NCT ID: NCT05466318

This clinical trial is comparing two treatment methods for patients with high-risk or relapsed lymphoma, specifically looking at a new combination therapy called ChiCGB, which includes chidamide, c...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanchong, Sichuan, China, Chendu, Sichuan, China +9 more

Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL

NCT ID: NCT05186558

This clinical trial is testing a new treatment approach for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a type of blood cancer. The study will give participants a co...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Hefei, Anhui, China, Changzhou, Jiangsu, China +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions